Last reviewed · How we verify
VersaPro Cream Base for Compounding — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
VersaPro Cream Base for Compounding (VersaPro Cream Base for Compounding) — CAMC Health System. VersaPro Cream Base is a pharmaceutical compounding vehicle that serves as an inert carrier for active pharmaceutical ingredients in topical formulations.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| VersaPro Cream Base for Compounding TARGET | VersaPro Cream Base for Compounding | CAMC Health System | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- VersaPro Cream Base for Compounding CI watch — RSS
- VersaPro Cream Base for Compounding CI watch — Atom
- VersaPro Cream Base for Compounding CI watch — JSON
- VersaPro Cream Base for Compounding alone — RSS
Cite this brief
Drug Landscape (2026). VersaPro Cream Base for Compounding — Competitive Intelligence Brief. https://druglandscape.com/ci/versapro-cream-base-for-compounding. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing